Half-year report · HY

Period2025-07-01 → 2025-12-31
Filed2026-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥2.4bn2025-07-01 → 2025-12-31Cons.Net sales
Revenue¥4.8bn2024-07-01 → 2025-06-30Cons.Net sales (5-year summary)
Revenue¥2.7bn2024-07-01 → 2024-12-31Cons.Net sales
Operating income¥231m2025-07-01 → 2025-12-31Cons.Operating income
Operating income−¥203m2024-07-01 → 2024-12-31Cons.Operating income
Ordinary income¥238m2025-07-01 → 2025-12-31Cons.Ordinary income
Ordinary income−¥129m2024-07-01 → 2025-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income−¥198m2024-07-01 → 2024-12-31Cons.Ordinary income
Profit before tax¥195m2025-07-01 → 2025-12-31Cons.Income before income taxes
Profit before tax−¥212m2024-07-01 → 2024-12-31Cons.Income before income taxes
Net income (owners)¥162m2025-07-01 → 2025-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥211m2024-07-01 → 2025-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥222m2024-07-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income¥162m2025-07-01 → 2025-12-31Cons.Profit loss
Net income−¥222m2024-07-01 → 2024-12-31Cons.Profit loss
Total assets¥6.7bnat 2025-12-31Cons.Assets
Total assets¥6.8bnat 2025-06-30Cons.Assets
Total assets¥6.6bnat 2024-12-31Cons.Total assets (5-year summary)
Total liabilities¥612mat 2025-12-31Cons.Liabilities
Total liabilities¥775mat 2025-06-30Cons.Liabilities
Net assets / equity¥6.1bnat 2025-12-31Cons.Net assets
Net assets / equity¥6.0bnat 2025-06-30Cons.Net assets
Net assets / equity¥6.0bnat 2024-12-31Cons.Net assets (5-year summary)
Cash and deposits¥5.0bnat 2025-12-31Cons.Cash and deposits
Cash and deposits¥5.0bnat 2025-06-30Cons.Cash and deposits
Cash & equivalents¥5.0bnat 2025-12-31Cons.Cash and cash equivalents
Cash & equivalents¥5.0bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.6bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.8bnat 2024-06-30vCons.Cash and cash equivalents
Operating cash flow¥134m2025-07-01 → 2025-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥558m2024-07-01 → 2025-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥98m2024-07-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Investing cash flow¥71m2025-07-01 → 2025-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥389m2024-07-01 → 2025-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥324m2024-07-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥139m2025-07-01 → 2025-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥214,0002024-07-01 → 2025-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥172,0002024-07-01 → 2024-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥6.192025-07-01 → 2025-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.052024-07-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.52024-07-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio90.8%at 2025-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio88.4%at 2025-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio91.3%at 2024-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 51
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2025-07-01 → 2025-12-31−¥16m
Reconciling Itemsreconcilingrevenue external2025-07-01 → 2025-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2025-07-01 → 2025-12-31−¥17m
Reconciling Itemsreconcilingsegment profit2025-07-01 → 2025-12-31−¥174m
Clinical Evidence Servicereportable segmentrevenue2025-07-01 → 2025-12-31¥131m
Clinical Evidence Servicereportable segmentrevenue external2025-07-01 → 2025-12-31¥131m
Clinical Evidence Servicereportable segmentsegment profit2025-07-01 → 2025-12-31¥11m
Functional Cosmetic Retailingreportable segmentrevenue2025-07-01 → 2025-12-31¥726m
Functional Cosmetic Retailingreportable segmentrevenue external2025-07-01 → 2025-12-31¥725m
Functional Cosmetic Retailingreportable segmentrevenue intersegment2025-07-01 → 2025-12-31¥919,000
Functional Cosmetic Retailingreportable segmentsegment profit2025-07-01 → 2025-12-31¥83m
Functional Food Retailingreportable segmentrevenue2025-07-01 → 2025-12-31¥933m
Functional Food Retailingreportable segmentrevenue external2025-07-01 → 2025-12-31¥926m
Functional Food Retailingreportable segmentrevenue intersegment2025-07-01 → 2025-12-31¥7m
Functional Food Retailingreportable segmentsegment profit2025-07-01 → 2025-12-31¥217m
Functional Material Developmentreportable segmentrevenue2025-07-01 → 2025-12-31¥180m
Functional Material Developmentreportable segmentrevenue external2025-07-01 → 2025-12-31¥171m
Functional Material Developmentreportable segmentrevenue intersegment2025-07-01 → 2025-12-31¥9m
Functional Material Developmentreportable segmentsegment profit2025-07-01 → 2025-12-31¥19m
Health Care Support Servicereportable segmentrevenue2025-07-01 → 2025-12-31¥460m
Health Care Support Servicereportable segmentrevenue external2025-07-01 → 2025-12-31¥460m
Health Care Support Servicereportable segmentsegment profit2025-07-01 → 2025-12-31¥75m
—segment totalrevenue2025-07-01 → 2025-12-31¥2.4bn
—segment totalrevenue external2025-07-01 → 2025-12-31¥2.4bn
—segment totalrevenue intersegment2025-07-01 → 2025-12-31¥17m
—segment totalsegment profit2025-07-01 → 2025-12-31¥404m
Reconciling Itemsreconcilingrevenue2024-07-01 → 2024-12-31−¥14m
Reconciling Itemsreconcilingrevenue external2024-07-01 → 2024-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2024-07-01 → 2024-12-31−¥15m
Reconciling Itemsreconcilingsegment profit2024-07-01 → 2024-12-31−¥159m
Clinical Evidence Servicereportable segmentrevenue2024-07-01 → 2024-12-31¥152m
Clinical Evidence Servicereportable segmentrevenue external2024-07-01 → 2024-12-31¥152m
Clinical Evidence Servicereportable segmentsegment profit2024-07-01 → 2024-12-31¥19m
Functional Cosmetic Retailingreportable segmentrevenue2024-07-01 → 2024-12-31¥751m
Functional Cosmetic Retailingreportable segmentrevenue external2024-07-01 → 2024-12-31¥751m
Functional Cosmetic Retailingreportable segmentsegment profit2024-07-01 → 2024-12-31¥25m
Functional Food Retailingreportable segmentrevenue2024-07-01 → 2024-12-31¥1.2bn
Functional Food Retailingreportable segmentrevenue external2024-07-01 → 2024-12-31¥1.2bn
Functional Food Retailingreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥4m
Functional Food Retailingreportable segmentsegment profit2024-07-01 → 2024-12-31−¥132m
Functional Material Developmentreportable segmentrevenue2024-07-01 → 2024-12-31¥183m
Functional Material Developmentreportable segmentrevenue external2024-07-01 → 2024-12-31¥173m
Functional Material Developmentreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥11m
Functional Material Developmentreportable segmentsegment profit2024-07-01 → 2024-12-31¥3m
Health Care Support Servicereportable segmentrevenue2024-07-01 → 2024-12-31¥393m
Health Care Support Servicereportable segmentrevenue external2024-07-01 → 2024-12-31¥393m
Health Care Support Servicereportable segmentsegment profit2024-07-01 → 2024-12-31¥39m
—segment totalrevenue2024-07-01 → 2024-12-31¥2.7bn
—segment totalrevenue external2024-07-01 → 2024-12-31¥2.7bn
—segment totalrevenue intersegment2024-07-01 → 2024-12-31¥15m
—segment totalsegment profit2024-07-01 → 2024-12-31−¥45m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 465
ItemContextValueUnit
Description of business (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus
Management analysis of financial position operating results and cash flows (text)FilingDateInstantText · Plus
Critical contracts (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所(グロース市場)
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)単元株式数100株
Details of employee share option program (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersInterimInstant_No1MajorShareholdersMember
Original text (Japanese)GOLONG HOLDING CO.,LIMITED(常任代理人 三田証券株式会社)
Address major shareholdersInterimInstant_No1MajorShareholdersMemberText · Plus
Name major shareholdersInterimInstant_No2MajorShareholdersMember
Original text (Japanese)梶本 修身
Address major shareholdersInterimInstant_No2MajorShareholdersMember
Original text (Japanese)東京都中央区
Name major shareholdersInterimInstant_No3MajorShareholdersMember
Original text (Japanese)光通信KK投資事業有限責任組合無限責任組合員光通信株式会社
Address major shareholdersInterimInstant_No3MajorShareholdersMember
Original text (Japanese)東京都豊島区西池袋1-4-10
Name major shareholdersInterimInstant_No4MajorShareholdersMember
Original text (Japanese)細川 陽介
Address major shareholdersInterimInstant_No4MajorShareholdersMember
Original text (Japanese)和歌山県和歌山市
Name major shareholdersInterimInstant_No5MajorShareholdersMember
Original text (Japanese)天野 謙二郎
Address major shareholdersInterimInstant_No5MajorShareholdersMember
Original text (Japanese)茨城県龍ケ崎市
Name major shareholdersInterimInstant_No6MajorShareholdersMember
Original text (Japanese)楽天証券株式会社
Address major shareholdersInterimInstant_No6MajorShareholdersMember
Original text (Japanese)東京都港区南青山2-6-21
Name major shareholdersInterimInstant_No7MajorShareholdersMember
Original text (Japanese)山下 敬弘
Address major shareholdersInterimInstant_No7MajorShareholdersMember
Original text (Japanese)茨城県土浦市
Name major shareholdersInterimInstant_No8MajorShareholdersMember
Original text (Japanese)INTERACTIVE BROKERS LLC(常任代理人 インタラクティブ・ブローカーズ証券株式会社)
Address major shareholdersInterimInstant_No8MajorShareholdersMemberText · Plus
Name major shareholdersInterimInstant_No9MajorShareholdersMember
Original text (Japanese)市川 敏夫
Address major shareholdersInterimInstant_No9MajorShareholdersMember
Original text (Japanese)東京都港区
Name major shareholdersInterimInstant_No10MajorShareholdersMember
Original text (Japanese)株式会社UH5
Address major shareholdersInterimInstant_No10MajorShareholdersMember
Original text (Japanese)東京都豊島区西池袋1-4-10
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsInterimInstant_SharesWithNoVotingRightsMember-
Description issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsOtherMember-
Description issued shares voting rightsInterimInstant_SharesWithFullVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsInterimInstant_SharesWithFullVotingRightsOtherMember-
Description issued shares voting rightsInterimInstant_SharesLessThanOneUnitMember-
Treasury shares etc (text)FilingDateInstantText · Plus
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which consolidated financial statements have been prepared financial informationInterimDurationText · Plus
Type1 semi annual consolidated financial statements financial informationInterimDurationText · Plus
Note on independent audit financial informationInterimDurationText · Plus
Type1 semi annual consolidated balance sheet (text)InterimDurationText · Plus
Type1 semi annual consolidated statement of income (text)InterimDurationText · Plus
Type1 semi annual consolidated statement of comprehensive income (text)InterimDurationText · Plus
Type1 semi annual consolidated statement of cash flows (text)InterimDurationText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-06-30pass rounding
balance sheet identityconsolidated 2025-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-06-30pass
statement vs summary · net assetsconsolidated 2025-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-07-01/2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2025-07-01/2025-12-31pass
statement vs summary · operating cash flowconsolidated 2024-07-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2025-07-01/2025-12-31pass
statement vs summary · revenueconsolidated 2024-07-01/2024-12-31pass
statement vs summary · revenueconsolidated 2025-07-01/2025-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass